← Back to Clinical Trials
Recruiting NCT05808036

NCT05808036 Efficacy of the DOMINO Diet App in IBS

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05808036
Status Recruiting
Phase
Sponsor Universitaire Ziekenhuizen KU Leuven
Condition Irritable Bowel Syndrome
Study Type INTERVENTIONAL
Enrollment 110 participants
Start Date 2023-04-01
Primary Completion 2026-08

Trial Parameters

Condition Irritable Bowel Syndrome
Sponsor Universitaire Ziekenhuizen KU Leuven
Study Type INTERVENTIONAL
Phase N/A
Enrollment 110
Sex ALL
Min Age 18 Years
Max Age 70 Years
Start Date 2023-04-01
Completion 2026-08
Interventions
Dietary intervention: DOMINO appDietary intervention: low FODMAP diet

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The aim of this study is to evaluate whether the DOMINO diet application is an effective tool in the treatment of Irritable bowel syndrome in tertiary care. Furthermore, this study aims to determine the response rate of the strict low FODMAP diet in non-responders to the DOMINO diet.

Eligibility Criteria

Inclusion Criteria: 1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures 2. Use of highly effective methods of birth control; defined as those that, alone or in combination, result in low failure rate (i.e., less than 1% per year) when used consistently and correctly; such as implants, injectables, combined oral contraceptives, some IUDs, true sexual abstinence (i.e. refraining from heterosexual intercourse during the entire period of risk associated with the Trial treatment(s)) or commitment to a vasectomised partner. 3. Patients with irritable bowel syndrome according to Rome IV diagnostic criteria 4. Patients ages between 18 and 70 years old Exclusion Criteria: 1. Participant has a history of any major psychiatric disorders (including those with a major psychosomatic element to their gastrointestinal disease), depression, alcohol or substance abuse in the last 2 years 2. Any disorder,

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology